Increased L1 retrotransposition in the neuronal genome in schizophrenia

Neuron

Volumn 81, Issue 2, 2014, Pages 306-313

  Bundo, Miki ^a,b   Toyoshima, Manabu ^b   Okada, Yohei ^c   Akamatsu, Wado ^c   Ueda, Junko ^b   Nemoto Miyauchi, Taeko ^b   Sunaga, Fumiko ^a   Toritsuka, Michihiro ^d   Ikawa, Daisuke ^d   Kakita, Akiyoshi ^e   Kato, Motoichiro ^c   Kasai, Kiyoto ^a   Kishimoto, Toshifumi ^d   Nawa, Hiroyuki ^e   Okano, Hideyuki ^c   Yoshikawa, Takeo ^b   Kato, Tadafumi ^b   Iwamoto, Kazuya ^a,f  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GENOMIC DNA; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME DELETION 22Q11; CONTROLLED STUDY; DNA TRANSPOSITION; EMBRYO; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE DOSAGE; GENE IDENTIFICATION; GENE INSERTION; GENE LOCATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; L1 GENE; MALE; MOUSE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SEQUENCE ANALYSIS;

22Q11 DELETION SYNDROME; ADULT; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA COPY NUMBER VARIATIONS; DNA TRANSPOSABLE ELEMENTS; ENDOGENOUS RETROVIRUSES; ENDONUCLEASES; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLASTS; GENE ONTOLOGY; GENETIC PREDISPOSITION TO DISEASE; GENOME; HUMANS; MACACA FASCICULARIS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PLURIPOTENT STEM CELLS; POLY I-C; POSTMORTEM CHANGES; PREFRONTAL CORTEX; PREGNANCY; PREGNANCY PROTEINS; RETT SYNDROME; RISK FACTORS; RNA-DIRECTED DNA POLYMERASE; SCHIZOPHRENIA; TRANSFECTION;

EID: 84892789989     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.10.053     Document Type: Article

References (41)

1. Baillie J.K., Barnett M.W., Upton K.R., Gerhardt D.J., Richmond T.A., De Sapio F., Brennan P.M., Rizzu P., Smith S., Fell M., et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 2011, 479:534-537.
2. Bloom F.E. Advancing a neurodevelopmental origin for schizophrenia. Arch. Gen. Psychiatry 1993, 50:224-227.
3. Brandon N.J., Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 2011, 12:707-722.
4. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 2006, 32:200-202.
5. Cobb S., Guy J., Bird A. Reversibility of functional deficits in experimental models of Rett syndrome. Biochem. Soc. Trans. 2010, 38:498-506.
6. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-923.
7. Cordaux R., Batzer M.A. The impact of retrotransposons on human genome evolution. Nat. Rev. Genet. 2009, 10:691-703.
8. Coufal N.G., Garcia-Perez J.L., Peng G.E., Yeo G.W., Mu Y., Lovci M.T., Morell M., O'Shea K.S., Moran J.V., Gage F.H. L1 retrotransposition in human neural progenitor cells. Nature 2009, 460:1127-1131.
9. Coufal N.G., Garcia-Perez J.L., Peng G.E., Marchetto M.C., Muotri A.R., Mu Y., Carson C.T., Macia A., Moran J.V., Gage F.H. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc. Natl. Acad. Sci. USA 2011, 108:20382-20387.
10. Drmanac R., Sparks A.B., Callow M.J., Halpern A.L., Burns N.L., Kermani B.G., Carnevali P., Nazarenko I., Nilsen G.B., Yeung G., et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010, 327:78-81.
11. Ehninger D., Li W., Fox K., Stryker M.P., Silva A.J. Reversing neurodevelopmental disorders in adults. Neuron 2008, 60:950-960.
12. Evrony G.D., Cai X., Lee E., Hills L.B., Elhosary P.C., Lehmann H.S., Parker J.J., Atabay K.D., Gilmore E.C., Poduri A., et al. Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell 2012, 151:483-496.
13. Giovanoli S., Engler H., Engler A., Richetto J., Voget M., Willi R., Winter C., Riva M.A., Mortensen P.B., Schedlowski M., Meyer U. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 2013, 339:1095-1099.
14. Hiroi N., Takahashi T., Hishimoto A., Izumi T., Boku S., Hiramoto T. Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol. Psychiatry 2013, 18:1153-1165.
15. Imaizumi Y., Okada Y., Akamatsu W., Koike M., Kuzumaki N., Hayakawa H., Nihira T., Kobayashi T., Ohyama M., Sato S., et al. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol. Brain 2012, 5:35.
16. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 2004, 9:406-416.
17. Iwamoto K., Bundo M., Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 2005, 14:241-253.
18. Iwamoto K., Bundo M., Ueda J., Oldham M.C., Ukai W., Hashimoto E., Saito T., Geschwind D.H., Kato T. Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 2011, 21:688-696.
19. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 2010, 11:402-416.
20. Keshavan M.S., Nasrallah H.A., Tandon R. Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophr. Res. 2011, 127:3-13.
21. Kuwabara T., Hsieh J., Muotri A., Yeo G., Warashina M., Lie D.C., Moore L., Nakashima K., Asashima M., Gage F.H. Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat. Neurosci. 2009, 12:1097-1105.
22. Lewis S.W., Murray R.M. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J. Psychiatr. Res. 1987, 21:413-421.
23. Meyer U., Feldon J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 2012, 62:1308-1321.
24. Mullen R.J., Buck C.R., Smith A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992, 116:201-211.
25. Muotri A.R., Gage F.H. Generation of neuronal variability and complexity. Nature 2006, 441:1087-1093.
26. Muotri A.R., Chu V.T., Marchetto M.C., Deng W., Moran J.V., Gage F.H. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005, 435:903-910.
27. Muotri A.R., Zhao C., Marchetto M.C., Gage F.H. Environmental influence on L1 retrotransposons in the adult hippocampus. Hippocampus 2009, 19:1002-1007.
28. Muotri A.R., Marchetto M.C., Coufal N.G., Oefner R., Yeo G., Nakashima K., Gage F.H. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010, 468:443-446.
29. Murray R.M., O'Callaghan E., Castle D.J., Lewis S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophr. Bull. 1992, 18:319-332.
30. Nawa H., Takahashi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol. Psychiatry 2000, 5:594-603.
31. Nawa H., Someya T., Sakai M. A novel schizophrenia model established by subcutaneously injecting a cytokine to a cynomolgus monkey neonate. Schizophr. Bull. 2009, 35(Suppl 1):252.
32. Poduri A., Evrony G.D., Cai X., Walsh C.A. Somatic mutation, genomic variation, and neurological disease. Science 2013, 341:1237758.
33. Rehen S.K., Yung Y.C., McCreight M.P., Kaushal D., Yang A.H., Almeida B.S., Kingsbury M.A., Cabral K.M., McConnell M.J., Anliker B., et al. Constitutional aneuploidy in the normal human brain. J. Neurosci. 2005, 25:2176-2180.
34. Shibata Y., Kumar P., Layer R., Willcox S., Gagan J.R., Griffith J.D., Dutta A. Extrachromosomal microDNAs and chromosomal microdeletions in normal tissues. Science 2012, 336:82-86.
35. Shibuya M., Komi E., Wang R., Kato T., Watanabe Y., Sakai M., Ozaki M., Someya T., Nawa H. Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism. J. Neural Transm. 2010, 117:887-895.
36. Spalding K.L., Bhardwaj R.D., Buchholz B.A., Druid H., Frisén J. Retrospective birth dating of cells in humans. Cell 2005, 122:133-143.
37. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
38. Toyosima M., Maekawa M., Toyota T., Iwayama Y., Arai M., Ichikawa T., Miyashita M., Arinami T., Itokawa M., Yoshikawa T. Schizophrenia with the 22q11.2 deletion and additional genetic defects: case history. Br. J. Psychiatry 2011, 199:245-246.
39. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
40. Yu F., Zingler N., Schumann G., Strätling W.H. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res. 2001, 29:4493-4501.
41. Yurov Y.B., Iourov I.Y., Vorsanova S.G., Liehr T., Kolotii A.D., Kutsev S.I., Pellestor F., Beresheva A.K., Demidova I.A., Kravets V.S., et al. Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS ONE 2007, 2:e558.